Phase i and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies

Y. Xu, J. M. Kolesar, L. J. Schaaf, R. Drengler, W. Duan, G. Otterson, C. Shapiro, J. Kuhn, M. A. Villalona-Calero

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science